This is a synthetic peptide designed for use in combination with anti-DHTKD1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Aufreinigung
Purified
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
DHTKD1
(Dehydrogenase E1 and Transketolase Domain Containing 1 (DHTKD1))
Synonyme
AMOXAD Peptide, CMT2Q Peptide, C330018I04Rik Peptide, dehydrogenase E1 and transketolase domain containing 1 Peptide, dehydrogenase E1 and transketolase domain containing 1 L homeolog Peptide, DHTKD1 Peptide, Dhtkd1 Peptide, dhtkd1.L Peptide
Hintergrund
The 2-oxoglutarate dehydrogenase complex catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO2. It contains multiple copies of three enzymatic components: 2-oxoglutarate dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2) and lipoamide dehydrogenase (E3).